| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Research Center for Experimental Biology, Tokyo Institute of Technology, Midori-ku, Yokohama 226-8501, Japan
Address all correspondence and requests for reprints to: Hiromi Hagiwara, Ph.D., Research Center for Experimental Biology, Tokyo Institute of Technology, 4259 Nagatsuta-cho, Midori-ku, Yokohama 226-8501, Japan. E-mail: hhagiwar{at}bio.titech.ac.jp
Osteoclasts are bone-resorbing multinucleated cells.
Tartrate-resistant acid phosphatase-positive (TRAP-positive)
mononuclear and multinucleated cells, which are osteoclast-like cells
(OCLs), were formed as a result of the coculture of mouse bone marrow
cells and clonal stromal ST2 cells in the presence of
1
,25-dihydroxyvitamin D3. Removal of ascorbic acid
from the culture medium prevented the formation of TRAP-positive OCLs.
Addition of ascorbic acid to the medium formed TRAP-positive OCLs, and
the effect of ascorbic acid was dose-dependent. When we examined the
level of messenger RNA (mRNA) for osteoclast differentiation factor
(RANKL/ODF) in ST2 cells, we found that ascorbic acid caused an
approximately 5-fold increase in the level of this mRNA. The half-life
of the mRNA was unaffected by ascorbic acid. To characterize the
mechanism of action of ascorbic acid, we investigated the relationship
between formation of TRAP-positive OCLs and formation of the collagen
matrix. Inhibitors of the formation of collagen triple helices blocked
both the formation of TRAP-positive OCLs and the expression of the mRNA
for RANKL/ODF in response to ascorbic acid. Our findings suggest that
ascorbic acid might be essential for osteoclastogenesis and might
induce the formation of TRAP-positive OCLs via induction of the
synthesis of RANKL/ODF that is somehow mediated by the extracellular
matrix.
This article has been cited by other articles:
![]() |
V. Geoffroy, M. Kneissel, B. Fournier, A. Boyde, and P. Matthias High Bone Resorption in Adult Aging Transgenic Mice Overexpressing Cbfa1/Runx2 in Cells of the Osteoblastic Lineage Mol. Cell. Biol., September 1, 2002; 22(17): 6222 - 6233. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |